findmyKOL

Gonzalo Revuelta, DO

Enriched profile

Associate Professor of Neurology and Medical Director of the Deep Brain Stimulation Program · Medical University of South Carolina (MUSC)

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Charleston, SC · Southeast · United StatesSpecialtyNeurologyFocusNeurological disorders and treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH funding2015–2026

Gonzalo Revuelta is Associate Professor of Neurology and Medical Director of the Deep Brain Stimulation Program at Medical University of South Carolina (MUSC). OpenAlex indexes 68 publications with 878 citations (h-index 16); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 11 Oct 2026

Overview

Updated 14 Oct 2026

Gonzalo Revuelta, D.O., is Associate Professor of Neurology and Medical Director of the Deep Brain Stimulation Program at Medical University of South Carolina (MUSC). The public record shows 68 publications with 878 citations (h-index 16), centered on Neurological disorders and treatments, Transcranial Magnetic Stimulation Studies, Parkinson's Disease Mechanisms and Treatments. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 8 companies, 2 NIH-funded awards (2015–2026).

  • Most recent indexed publication: 2026 · The European journal of neuroscience
  • Top research focus: Neurological disorders and treatments
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Parkinson's Disease5 trials

Research focus

OpenAlex concept fingerprint
Neurological disorders and treatmentsTranscranial Magnetic Stimulation StudiesParkinson's Disease Mechanisms and TreatmentsBalance, Gait, and Falls PreventionObsessive-Compulsive Spectrum Disorders

Drugs & molecules

across trials, industry payments and publications
Gocovrigeneric · AmantadineClinical trials—Industry payments10Publications1Nourianzgeneric · IstradefyllineClinical trials—Industry payments1Publications—Qelbreegeneric · ViloxazineClinical trials—Industry payments1Publications—Rytarygeneric · Carbidopa / levodopaClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
MDD US Operations, LLCClinical trials—Industry payments11Abbott LaboratoriesClinical trials—Industry payments10InSightec,IncClinical trials—Industry payments8Boston Scientific CorporationClinical trials—Industry payments4Medical University of South CarolinaClinical trials4Industry payments—Medtronic, Inc.Clinical trials—Industry payments4Amneal Pharmaceuticals LLCClinical trials—Industry payments1Kyowa Kirin, Inc.Clinical trials—Industry payments1Parkinson's FoundationClinical trials1Industry payments—Supernus Pharmaceuticals, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
68publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

878citations

Total citations across indexed works.

16h-index

Hirsch index (OpenAlex). i10-index 22.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2015–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    95.7%
    Aromatic Amino Acid Decarboxylation Inhibitor31.7%
    Carbidopa-Levodopa44%Rytary37%Carbidopa-Levodopa Er19%
    Part D≥61 patients
    Influenza A M2 Protein Inhibitor14.5%
    Gocovri70%Amantadine30%
    Part D≥16 patients

    + 13 more classes in this area

  • Cardiovascular

    3%
    alpha-Adrenergic Agonist1.7%
    Midodrine Hcl100%
    Part D<11 patients
    Adrenergic and dopaminergic agents1.3%
    Droxidopa100%
    Part D<11 patients
  • Musculoskeletal

    1.4%
    gamma-Aminobutyric Acid-ergic Agonist1.4%
    Baclofen100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

2 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Daniel H. Lench13Mark S. George10Nolan Williams8Steven A. Kautz7Gregory L. Sahlem7Aaron E. Embry6Lisa M. McTeague6Holly H Fleischmann6Michael U. Antonucci6Travis H. Turner6Katrina S. Rbeiz6Stewart Alan Factor6Olivia Horn6Andreana M. Benitez6Nathan Christopher Rowland6Carol Frances Lippa6Stephanie Aghamoosa5Colleen A. Hanlon5Jens H. Jensen5Michele Tagliati4Rajesh Pahwa4Corneliu C. Luca4Shonna L. Jenkins4Jill L. Ostrem4Joshua M. Rosenow4Leonardo Bonilha4Federico E Rodriguez‐Porcel4Baron Short4James W. Lopez4Kevin A. Caulfield4Mustafa Siddiqui4Ryan J. Uitti3Mark F. Sedrak3Mahlon R. DeLong3Marian L. Dale3Donald M. Whiting3Jaspreet Pannu3Michał Gostkowski3Alon Y. Mogilner3Adam Olding Hebb3

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Neurology residency

    Drexel University College of Medicine (2008); Movement Disorders and Deep Brain Stimulation fellowship, Emory University School of Medicine

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
  • DO

    University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine

    2004
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗

Editorial & leadership roles

journal and society appointments
  • Member

    International Parkinson's Disease and Movement Disorder Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
  • Member

    Parkinson Study Group

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
  • Member

    Huntington Study Group

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
  • Member

    Dystonia Coalition

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.